Baxter International Inc.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infus…
Medical - Instruments & Supplies
US, Deerfield [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 0.04 | 1.48 | 1.48 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 9.04 | 16.71 | 15.32 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | -2.92 | 16.09 | 16.57 | |
| Cash | -5.45 | 5.96 | 6.30 | |
| Capex | 7.55 | -0.35 | -0.37 | |
| Free Cash Flow | -96.20 | -0.03 | 0.67 | |
| Revenue | -7.72 | 7.07 | 7.66 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -0.95 | 0.38 | 0.38 | |
| Operating Margin | 9.14 | 0.09 | 0.08 | |
| ROA | -84.63 | < 0.005 | < 0.005 | |
| ROE | -84.47 | < 0.005 | 0.03 | |
| ROIC | 14.99 | < 0.005 | < 0.005 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of BAX is permitted for members.
5
Growth
The "Growth Entry" for the Focus of BAX is permitted for members.
6
Leverage & Liquidity